Your browser doesn't support javascript.
loading
Impact of achieving euthyroidism on pulmonary artery systolic pressures in hyperthyroidism-associated pulmonary hypertension - a systematic review.
Chacko, Shireen R; Ram, Pradhum; Fox, Tamaryn; Sooknanan, Naveen; Lo, Kevin Bryan; Menezes, Ritesh G; Lasrado, Savita; Eiger, Glenn; Vaidya, Anjali.
Afiliação
  • Chacko SR; Department of Medicine, Albert Einstein Medical Center Philadelphia PA, United States of America.
  • Ram P; Division of Cardiology, Emory University Hospital Atlanta, GA, United States of America.
  • Fox T; Department of Medicine, Albert Einstein Medical Center Philadelphia PA, United States of America.
  • Sooknanan N; Department of Medicine, Albert Einstein Medical Center Philadelphia PA, United States of America.
  • Lo KB; Department of Medicine, Albert Einstein Medical Center Philadelphia PA, United States of America.
  • Menezes RG; Department of Pathology, College of Medicine, King Fahd Hospital of The University, Imam Abdulrahman Bin Faisal University Dammam, Saudi Arabia.
  • Lasrado S; Department of Otorhinolaryngology and Head & Neck Surgery, Father Muller Medical College Mangalore, India.
  • Eiger G; Department of Medicine, Albert Einstein Medical Center Philadelphia PA, United States of America.
  • Vaidya A; Division of Pulmonary and Critical Care and Sleep Medicine, Einstein Medical Center Philadelphia PA, United States of America.
Am J Cardiovasc Dis ; 12(4): 212-223, 2022.
Article em En | MEDLINE | ID: mdl-36147789
ABSTRACT
In this systematic review, we seek to clarify the impact of treatment of hyperthyroidism on pulmonary hypertension in patients with both these conditions. We included 39 of 709 articles retrieved, that studied patients with hyperthyroidism and pulmonary hypertension (PH). From these, those with a documented pre-treatment Pulmonary Artery Systolic Pressure (PASP) > 35 mmHg and complete follow up were analyzed, yielding 3 case series and 22 case reports with a total of 81 cases. A significant improvement in PASP was noted with achieving euthyroidism in the 3 case series. The case reports showed a significant reduction in mean PASP from 60.5 ± 13.2 mmHg to 37.5 ± 10.1 mmHg (p < 0.001) in patients with Grave's disease with achieving euthyroidism. No deaths were reported during the follow up period. Achievement of a euthyroid state in patients with hyperthyroidism is associated with statistically significant reductions in PASP.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Revista: Am J Cardiovasc Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Revista: Am J Cardiovasc Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos